BCMA Re-Emergence As a Prognostic Indicator of Clinical Relapse after Chimeric Antigen Receptor T-Cell Therapy (CART) in Multiple Myeloma

被引：0
|
作者：
Rashid, Aliya [1 ,2 ,3 ]
Wesson, William [2 ,4 ,5 ]
Lutfi, Forat [1 ,5 ]
Mushtaq, Muhammad Umair [5 ]
McGuirk, Joseph P. [5 ,6 ]
Abdallah, Al-Ola
Cui, Wei [7 ]
Ahmed, Nausheen [5 ]
机构：
[1] US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA
[2] Univ Kansas, Div Hematol Malignancies & Cellular Therapeut, Ctr Canc, Kansas City, MO USA
[3] Univ Kansas, Med Ctr, Internal Med, Kansas City, KS USA
[4] Univ Kansas, Sch Med, Kansas City, KS USA
[5] Univ Kansas, Div Hematol Malignancies & Cellular Therapeut, Med Ctr, Kansas City, KS USA
[6] Univ Kansas, Med Ctr, Westwood, KS USA
[7] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182126
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma-Challenges and Potential Solutions
    Al Hadidi, Samer
    Zangari, Maurizio
    van Rhee, Frits
    JAMA ONCOLOGY, 2022, 8 (06) : 823 - 824
  • [32] Overcoming Chimeric Antigen Receptor (CAR) Modified T-Cell Therapy Limitations in Multiple Myeloma
    Garcia-Guerrero, Estefania
    Sierro-Martinez, Belen
    Perez-Simon, Jose Antonio
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [33] Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma
    Huang, He
    uW, Heng-wei
    Hu, Yong-xian
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2020, 21 (01): : 29 - 41
  • [34] Real world experience of patients treated with idecabtagene vicleucel: a BCMA-directed chimeric antigen receptor T-cell therapy for multiple myeloma
    Canonico, Dalton
    Laubach, Jacob
    Mo, Clifton
    Sperling, Adam
    Nikiforow, Sarah
    Redd, Robert
    Ramsdell, Linda
    McDermott, Kathleen
    Finn, Kathleen
    Desnoyers, Lauren
    Jacobson, Caron
    Bianchi, Giada
    Midha, Shonali
    Hartley-Brown, Monique
    Ghobrial, Irene
    Anderson, Kenneth
    Munshi, Nikhil
    Nadeem, Omar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S39 - S39
  • [35] Patterns of Failure in Multiple Myeloma with Extramedullary Disease Following Anti-BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Nakashima, J. Y.
    Khatri, V.
    Cruz-Chamorro, R. J.
    Zhou, J.
    Patra, P.
    Gonzalez, R.
    De Avila, G.
    Locke, F. L.
    Liu, H. D.
    Nishihori, T.
    Puglianini, O. C.
    Alsina, M.
    Garjales-Cruz, A.
    Baz, R.
    Shah, B. D.
    Shain, K.
    Jain, M. D.
    Hansen, D.
    Freeman, C.
    Figura, N. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S206 - S207
  • [36] Safety and Efficacy of B-Cell Maturation Antigen (BCMA)-Specific Chimeric Antigen Receptor T Cells (CART-BCMA) with Cyclophosphamide Conditioning for Refractory Multiple Myeloma (MM)
    Cohen, Adam D.
    Garfall, Alfred L.
    Stadtmauer, Edward A.
    Lacey, Simon F.
    Lancaster, Eric
    Vogl, Dan T.
    Weiss, Brendan M.
    Ambrose, David E.
    Nelson, Anne Marie
    Chen, Fang
    Plesa, Gabriela
    Kulikovskaya, Irina
    Gonzalez, Vanessa
    Gupta, Minnal
    Young, Regina M.
    Dengel, Karen
    O'keefe, Laura
    Le, Samantha
    Richardson, Celeste
    Isaacs, Randi E.
    Melenhorst, J. Joseph
    Levine, Bruce L.
    June, Carl H.
    Milone, Michael C.
    BLOOD, 2017, 130
  • [37] Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma Network
    Moreau, Philippe
    Sonneveld, Pieter
    Boccadoro, Mario
    Cook, Gordon
    Victoria Mateos, Ma
    Nahi, Hareth
    Goldschmidt, Hartmut
    Dimopoulos, Meletios A.
    Lucio, Paulo
    Blade, Joan
    Delforge, Michel
    Hajek, Roman
    Ludwig, Heinz
    Facon, Thierry
    San Miguel, Jesus F.
    Einsele, Hermann
    HAEMATOLOGICA, 2019, 104 (12) : 2358 - 2360
  • [38] Significance of alkaline Phosphatase After Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma
    Dong, Rujiao
    Wang, Yudi
    Sun, Xiaohong
    Lin, Yuanyuan
    Luo, Yuqing
    Xing, Chongyun
    Sun, Lan
    Zhang, Shenghui
    Yu, Kang
    Jiang, Songfu
    Chen, Yi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (12): : 911 - 916
  • [39] Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myeloma
    Dingli, Sarah
    Rothweiler, Paul
    Binder, Moritz
    Cook, Joselle
    Gertz, Morie A.
    Hayman, Suzanne
    Kapoor, Prashant
    Kourelis, Taxiarchis
    Kumar, Shaji K.
    Siddiqui, Mustaqeem
    Warsame, Rahma
    Lin, Yi
    Erdman, Arthur G.
    Dingli, David
    LEUKEMIA, 2025, : 1005 - 1008
  • [40] Vitamin D deficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma
    Nishimura, Noriko
    Flynn, Jessica
    Costa, Bruno
    Devlin, Sean
    Farzana, Tasmin
    Chung, David
    Landau, Heather
    Lahoud, Oscar
    Scordo, Michael
    Shah, Gunjan
    Hassoun, Hani
    Maclachlan, Kylee
    Hultcrantz, Malin
    Korde, Neha
    Lesokhin, Alexander
    Shah, Urvi
    Tan, Carlyn Rose
    Giralt, Sergio
    Usmani, Saad
    Mailankody, Sham
    Nath, Karthik
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S55 - S56
12345